Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Methanol | HCID 887 | — |
| Reactant | Methanesulfonic Acid | HCID 6395 | — |
| Reactant | Ethyl Acetate | HCID 8857 | — |
| Reactant | Tivozanib | HCID 9911830 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 86603570 | HCID 86603570 | 82.6% |
Reaction Steps
N-{2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-N′-(5-methyl-3-isoxazolyl)urea (2.0 g) produced in Production Example was added to methanol (50 mL), methanesulfonic acid (1.3 g) was added dropwise thereto, and the mixture was stirred at room temperature for 4 hr. The resultant precipitate was collected by filtration, and the filtered product was then dried under the reduced pressure. The powder thus obtained was stirred in N,N-dimethylformamide (5 mL) at 100° C. for complete dissolution. The solution was then cooled to room temperature. Ethyl acetate (20 mL) was added dropwise thereto, and the mixture was stirred at room temperature overnight. The resultant precipitate was filtered, and the filtered product was then dried under the reduced pressure to give a form V crystal of N-{2-chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-N′-(5-methyl-3-isoxazolyl)urea methanesulfonate (2.0 g, yield 82.0%).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07166722B2 |
|---|
| Source dataset | uspto-grants-2007_01 |
|---|
| ORD ID | ord-d62204c3130648ffbc1bc03e23ac70ee |
|---|
| Source note | uspto-grants-2007_01 |
|---|